Object reference not set to an instance of an object. Online Stock Broker - Stock Broking, Best Share Bazaar Brokers In India
Close
  • SMC open account icon Open an A/C
    • Open an A/C
    • CHOOSE YOUR OPTION(S)
    • Trading A/c
    • Mutual Fund A/c
    • NBFC A/c
    • NPS A/c

Budget News

  • Benchmarks turn negative; Nifty below 14,350
  • April 20,2021  14:28
  • The equity benchmarks reversed trend and hit a fresh intraday low in mid-afternoon trade. Pharma shares extended gains for the fourth day. The Nifty slipped below the 14,350 mark.

    At 14:26 IST, the barometer index, the S&P BSE Sensex, was down 209.95 points or 0.44% to 47,739.47. The Nifty 50 index lost 37.35 points or 0.26% to 14,322.10.

    In the broader market, the S&P BSE Mid-Cap index and the S&P BSE Small-Cap index, both advanced 0.80%.

    Buyers outnumbered sellers. On the BSE, 1765 shares rose and 1051 shares fell. A total of 159 shares were unchanged.

    Numbers to Track:

    In the foreign exchange market, the partially convertible rupee rose to 74.7525 compared with its previous closing of 74.87.

    The yield on 10-year benchmark federal paper rose to 6.098% as compared to its previous close of 6.081%.

    MCX Gold futures for 4 June 2021 settlement slipped 0.34% to Rs 47,232.

    The US Dollar index (DXY), which tracks the greenback's value against a basket of currencies, shed 0.14% to 90.94.

    In the commodities market, Brent crude for June 2021 settlement rose 85 cents to $67.90 a barrel. The contract added 0.42% or 28 cents to settle at $67.05 in the previous trading session.

    Buzzing Index:

    The Nifty Pharma index rose 2.33% to 13,565.20. The index has added 5.92% in four sessions.

    Cadila Healthcare (up 6.86%), Dr. Reddy's Labs (up 4.57%), Aurobindo Pharma (up 3.47%), Sun Pharma (up 2.68%), Lupin (up 2.63%), Cipla (up 1.33%) and Torrent Pharma (up 1.07%) advanced.

    Stocks in Spotlight:

    Max Ventures and Industries rose 4.55% to Rs 56.30 after the company said its subsidiary Max Speciality Films (MSFL) has commercialized its new advanced metallizer line. MSFL manufactures specialty packaging films.

    In December 2020, MSFL had said that it would be installing two additional metallizer lines. MSFL has commenced first of the two metallizer lines today (20 April 2021)”, Max Ventures said in a statement.

    Symphony surged 8.78% to Rs 1240.15 amid heavy volumes. On the BSE, 33,438 shares of the company were traded in the counter so far compared with the three-month average trading volume of 8,204 shares.

    On the NSE, the counter clocked volume of 11,86,038 shares compared with average trading volume of 120,897 shares in the past three-months.

    Powered by Capital Market - Live News

Economy News
Global News

Follow us:

  • fb icon
  • Twitter icon
  • Linkedin
  • you tube
  • Instagram

Disclaimer:

SMC Global Securities Ltd | CIN : L74899DL1994PLC063609 | Registered Office: 11/6B, Shanti Chamber, Pusa Road, Delhi-110005. | Tel +91-11-30111000 | Compliance Officer: Mr. Ashok Kumar Aggarwal | Tel 011-30111000 Extn. 170 | Email:-aka@smcindiaonline.com| Customer Care Email –smc.care@smcindiaonline.com| Complaint Email –igc@smcindiaonline.com| website: www.smctradeonline.com

SEBI Reg. No. INZ000199438, Member: NSE (07714), BSE (470), MSEI (1002), MCX (8200) & NCDEX (00021). DP SEBI Regn. No. CDSL/NSDL-IN-DP-130-2015, SMC Research Analyst Registration- INH100001849, Mutual Funds Distributor ARN No. 29345. •Insurance services are offered through SMC Insurance Brokers Pvt. Ltd. IRDAI Regn. No: DB 272/04 License No. 289 Valid upto 27/01/2026. • Real Estate Advisory services are offered through SMC Real Estate Advisors Pvt. Ltd.

Disclaimer: Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Mutual Fund investments are subject to market risks. Read all scheme related documents carefully. PMS is not offered in commodity derivative segment. Insurance is the subject matter of solicitation. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Past performance should not be taken as an indication or guarantee of future performance, and no representation or warranty, express or implied, is made regarding future performance. The price, value of and income from any of the securities or financial instruments mentioned in this report can fall as well as rise.

By submitting your details to SMC, you are authorizing us to send promotional communication through Call/Email/SMS/Whatsapp even though you may be registered under DND.

OUR OTHER WEBSITES Go
IMPORTANT LINKS Go
QUICK LINKS
Go

Toll-free : 1800-11-0909
Email: contact@smctradeonline.com

Sitemap
Plus Minus 
Copyright ©2016-2024 SMC. All Rights Reserved | Disclaimer | Privacy Policy | Copyright| Testimonials| Sitemap| Grievance| design agency: triverse| Powered by C-MOTS Infotech (ISO 9001:2015 certified)

Open my trading account now!  X 

* All fields are compulsory